Abstract
Since the original reports by Isaacs and Lindenmann (1957 a, b), the use of interferon (IFN) in the prevention and treatment of virus infections has been anticipated. Because of its broad spectrum of antiviral activity, viral infections of the respiratory tract, eye, and skin have been appropriate targets for the potential utilization of IFN. However, only in the past few years have sufficient quantities of IFN been available for clinical evaluation in humans. Thus, there have been few controlled studies with HuIFN, but several anecdotal reports. This chapter will focus on both the basic anatomic and physiologic considerations which pertain to clinical efficacy, and the studies performed to date with locally applied IFN.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Adler KB, Wooten O, Dulfano MJ (1973) Mammalian respiratory mucociliary clearance. Arch Environ Health 27:364–367
Ali MY (1965) Histology of the human nasopharyngeal mucosa. J Anat 99:657–672
Andersen I (1974) A comparison of nasal and tracheobronchial clearance. Arch Environ Health 29:290–293
Andersen I, Lundqvist, Proctor DF (1971) Human nasal mucosal function in a controlled climate. Arch Environ Health 23:408–420
Andersen I, Lundqvist, Proctor DF (1972) Human nasal mucosal function under four controlled humidities. Am Rev Respir Dis 106:439–449
Andersen I, Lundqvist G, Jensen PL, Proctor DF (1974) Human response to controlled levels of sulfur dioxide. Arch Environ Health 28:31–39
Aoki FY, Crawley J (1976) Distribution and removal of human serum albumin-technetium 99m instilled intranasally by drops and spray. Br J Clin Pharm 3:869–878
Arnaoudova V (1976) Treatment and prevention of acute respiratory virus infections in children with leukocytic interferon. Rev Roum Med Virol 27:89–91
Bang BG (1961) The surface pattern of the nasal mucosa and its relation to mucosa and its relation to mucus flow. J Morphol 109:57–72
Bang BG, Mukherjee AL, Bang FB (1967) Human nasal mucus flow rates. John Hopkins Med J 121:38–48
Bang BG, Bang FB (1977 a) Nasal mucociliary systems. In: Brian JD, Proctor DF, Reid LM (eds) Respiratory defense mechanisms, vol 5. Dekker, New York, p 405
Bang FB, Bang BG (1977b) Mucous membrane injury and repair. In: Brain JD, Proctor DF, Reid LM (eds) Respiratory defense mechanisms, vol 5. Dekker, New York, p 453
Blake JR, Sleight MA (1974) Mechanics of ciliary locomotion. Biol Rev 49:85–105
Boat TF, Kleinerman JI (1975) Human respiratory tract secretions. 2. Effect of cholinergic and adrenergic agents on in vitro release of protein and mucous glycoprotein. Chest 67 [Suppl]:325
Boling LR (1935) Regeneration of nasal mucosa. Arch Otolaryngol 22:689–724
Brain JD, Valberg PA (1979) Deposition of Aerosol in the respiratory tract. Am Rev Respir Dis 120:1325–1373
Brettschneider H (1958) Electromicroscopic studies of the nasal mucosa. Amt Anz 105:194–204
Bucknall RA (1976) Why aren’t antivirals effective when administered intranasally. In: Oxford JS, Williams JD (eds) Chemotherapy and control of influenza. Academic, New York, p 77
Came PE, Schafer TW, Silver GH (1976) Sensitivity of rhino viruses to human leukocyte and fibroblast interferons. J Infect Dis 133 [Suppl]:A 136–139
Camner P, Philipson K, Linnman L (1971) A simple method for nuclidic tagging of mono-disperse fluorocarbon resin particles. Int J Appl Radiat Isot 22:731–734
Cantell K, Tommila V (1960) Effect of interferon on experimental vaccinia and herpes-simplex virus infections in rabbits eyes. Lancet 2:682–684
Cantell K, Hirvonen S, Mogensen KE, Pyhala I (1974) Human leukocyte interferon: production, purification, stability, and animal experiments. In: Waymouth C (ed) The production and use of interferon for the treatment and prevention of human virus infections. Tissue Culture Association, Rockville, p 35
Cesario TC (1977) The effect of body fluids on polynucleotide-induced fibroblast interferon and virus-induced leukocyte interferon. Proc Soc Exp Biol Med 155:583–587
Cesario TC, Mandell A, Tilles JG (1973) Inactivation of human interferon by body fluids. Proc Soc Exp Biol Med 144:1030–1032
Cogan D, Hirsch E, Kinsey V (1944) Permeability characteristics of the excised cornea. Arch Ophthalmol 31:408
Condon WB (1942) Regeneration of tracheal and bronchial epithelium. J Thorac Surg 11:333–346
Connolly JH, Dick GWA, Field CMB (1962) A fatal case of progressive vaccinia. Br Med J 1:1315–1317
Coster DJ, Falcon MG, Cantell K, Jones BR (1977) Clinical experience of human leucocyte interferon in the management of herpetic keratitis. Trans Ophthalmol Soc UK 97(2):32–326
Creeth JM (1978) Constituents of mucus and their separation. Br Med Bull 34:17–24
DeKoning EWG, van Bijsterveld OP, Cantell K (1982) Combination therapy for dendritic keratitis with human leucocyte interferon and trifluorothymidine. Br J Ophthalmol 66:509–512
De la Pena NC, Diaz A, Damel A, Bal E, Puricelli L, Ejden J, Lusting ES de (1978) Combined therapy of human interferon (HI) and secretory immunoglobulin (S-IgA) in the treatment of human herpetic keratitis. Biomedicine 28:104–108
Dianzani F, Baron S (1977) The continued presence of interferon is not required for activation of cells by interferon. Proc Soc Exp Biol Med 155:562–566
Dion MC, Jafek BW, Tobin CE (1978) The anatomy of the nose. Arch Otolaryngol 104:145–150
Drettner B (1961) Vascular reactions of the human nasal mucosa on exposure to cold. Acta Otolaryngol Suppl (Stockh) 166:1
Ewert G (1965) On the mucus flow rate in the human nose. Acta Otolaryngol Suppl (Stockh) 200:1–60
Ford LC, DeLange RJ, Petty RW (1976) Identification of a nonlysozymal bacterial factor (beta lysin) in human tears and aqueous humor. Am J Ophthalmol 81:30–33
Foster WM, Bergofsky EH, Bohning DE, Lippmann M, Albert RE (1976) Effect of adrenergic agents and their mode of action on mucociliary clearance in man. J Appl Physiol 41:146–152
Friedenwald J, Hughes W, Hermann H (1944) Acid base tolerance of the cornea. Arch Ophthalmol 31:279
Fry FA (1970) Charge distribution on polystyrene aerosols and deposition in the human nose. J Aerosol Sci 1:135–146
Fry FA, Black A (1973) Regional deposition and clearance of particles in the human nose. J Aerosol Sci 4:113–124
Gorham CB, Bacher JA (1930) Regeneration of the human maxillary antral lining. Arch Otolaryngol 11:763–771
Graziadei PPC (1970) Nasal mucous membranes. Ann Otol 79:422–433
Greenberg SB, Harmon MW, Johnson PE, Couch RB (1978) Antiviral activity of intranasally applied human leukocyte interferon. Antimicrob Agents Chemother 14:596–600
Greenberg SB, Harmon MW, Couch RB, Johnson PE, Wilson SZ, Dacso CC, Bloom K, Quarles J (1982) Prophylactic effect of low doses of human leukocyte interferon against infection with rhinovirus. J Infect Dis 145:542–546
Harmon MW, Greenberg SB, Couch RB (1976) Effect of human nasal secretions on the antiviral activity of human fibroblast and leukocyte interferon. Proc Soc Exp Biol Med 152:598–602
Harmon MW, Greenberg SB, Johnson PE, Couch RB (1977) Human nasal epithelial cell culture system: evaluation of response to human interferons. Infect Immunol 16:480–485
Harmon MW, Greenberg SB, Johnson PE (1980) Rapid onset of the interferon-induced antiviral state in human nasal epithelial and foreskin fibroblast cells. Proc Soc Exp Biol Med 164:146–152
Harris J (1960) Transport of fluid from the cornea. In: Duke-Elder S (ed) Transparency of the cornea. Thomas, Springfield, p 73
Hasegawa M, Kern EB (1977) The human nasal cycle. Mayo Clin Proc 52:27–34
Heyder J, Gebhart G, Heigwer CR, Roth C, Stahlhofen W (1973) Experimental studies of the total disposition of aerosol particles in the human respiratory tract. J Aerosol Sci 4:191–208
Hilding A (1931) Ciliary activity and course of secretion currents of the nose. Proc Mayo Clin 6:285–287
Hilding A (1932) the physiology of drainage of nasal mucus. Arch Otolaryngol 15:92–100
Hilding AC (1965) Regeneration of respiratory epithelium after minimal surface trauma. Ann Otol Rhinol Laryngol 74:903–914
Holly FJ, Lemp MA (1977) Tear physiology and dry eyes. Surv Ophthalmol 22:69–87
Hounam RF, Black A, Walsh M (1971) The deposition of aerosol particles in the nasopharyngeal region of the human respiratory tract. In: Walton WH (ed) Inhaled particles III. Unwin, Old Woking Surrey, p 71
Hounam RF (1975) The removal of particles from the nasopharyngeal (NP) compartment of the respiratory tract by nose blowing and swabbing. Health Phys 28:743–745
Ikic D, Petricevic I, Soldo I, Soos E, Smerdel S, Jusic D (1975a) Treatment with human leukocyte interferon. In: Proceedings of the symposium on clinical use of interferon, Yugoslavia Academy of Sciences and Arts, Zagreb, p 183
Ikic D, Cupak K, Trajer D, Soos E, Jusic D, Smerdel S (1975 b) Therapy and prevention of epidemic keratoconjunctivitis with human leukocyte interferon. In: Proceedings of the symposium on clinical use of interferon, Yugoslavia Academy of Sciences and Arts, Zagreb, p 189
Ikic D, Smerdel S, Rajninger-Miholic R, Soos E, Jusic D (1975c) Treatment of labial and genital herpes with human leukocytic interferon. In: Proceedings of the symposium on clinical use of interferon, Yugoslavia Academy of Sciences and Arts, Zagreb, p 195
Ikic D, Orescanin M, Krusic J, Cestar Z (1975d) Preliminary study of the effect of human leukocytic interferon on condylomata acuminata in women. In: Proceedings of the symposium on clinical use of interferon, Yougoslav Academy of Sciences and Arts, Zagreb, p 223
Ikic D, Brnobic A, Jurkovic-Vukelic V, Smerdel S, Jusic D, Soos E (1975e) Therapeutical effect of human leukocyte interferon incorporated into ointment and cream on condylomata acuminata. In: Proceedings of the symposium on clinical use of interferon, Yugoslav Academy of Sciences and Arts, Zagreb, p 235
Imanishi J, Karaki T, Sasaki O, Matsuo A, Oishi K, Pak CB, Kishida T, Toda S, Nagata H (1980) The preventive effect of human interferon-alpha preparation on upper respiratory disease. J Interferon Res 1:169–178
Iravani J, Melville GN (1976) Mucociliary function in the respiratory tract by physico-chemical factors. Pharmacol Ther 2:471–492
Isaacs A, Lindenmann J (1957a) Virus interference. I. The interferon. Proc R Soc Lond [Biol] 147:258–267
Isaacs A, Lindenmann J, Valentine RC (1957b) Virus interference. II. Some properties of interferon. Proc R Soc Lond [Biol] 147:268–273
Isaacs A, Westwood MA (1959) Inhibition by interferon of the growth of vaccinia virus in the rabbit skin. Lancet 2:324–325
Ishii T (1970) The cholinergic innervation of the human nasal mucosa. Pract Otorhinolaryngol 32:153–161
Jakus M (1961) The fine structure of the human cornea. In: Smelser G (ed) The structure of the eye. Academy, New York, p 344
Johnson PE, Greenberg SB, Harmon MW, Alford BR, Couch RB (1976) Recovery of applied human leukocyte interferon from the nasal mucosa of chimpanzees and human leukocyte interferon from the nasal mucosa of chimpanzees and humans. J Clin Microbiol 4:106–107
Jones BR, Galbraith JEK, Al-Hussaini MK (1962) Vaccinial keratitis treated with interferon. Lancet I:875–879
Jones BR, Galbraith JEK, Al-Hussaini MK (1976a) Clinical trials of topical interferon therapy of ulcerative viral keratitis. J Infect Dis 133:169–172
Jones BR, Coster DJ, Falcon MG, Cantell K (1976b) Topical therapy of ulcerative herpetic keratitis with human interferon. Lancet II: 128
Kaufman HE, Ellison ED, Centifanto YW (1972) Difference in interferon response from ocular virus infection in rabbits and monkeys. Am J Ophthalmol 74:89–92
Kaufmann HE, Meyer RF, Laibson PR, Waltman SR, Nesburn AB, Shuster JJ (1976) Human leukocyte interferon for the prevention of recurrences of herpetic keratitis. J Infect Dis 133:165–168
Knowlton CD, McGregor GW (1928) How and when the mucous membrane of the maxillary sinus regenerates. Arch Otolaryngol 8:647–656
Kobza K, Emodi G, Just M, Hilti E, Leuenberger A, Binswanger U, Thiel G, Brunner FP (1975) Treatment of herpes infection with human exogenous interferon. Lancet I:1343–1344
Krasikova VA, Poddubnaia AE, Ritova VV, Schastny’i EI, Kuznetsov VP (1977) Interferongenesis and efficacy of refined leukocytic interferon use in acute respiratory viral infections in premature children. Pediatriia 5:42–48
Krogh A, Lund CC, Pedersen-Bjergaard K (1945) The osmotic concentration of human lacrimal fluid. Acta Physiol Scand 10:88–92
Landahl HD (1950) On the removal of air-borne droplets by the human respiratory tract: II. The nasal passages. Bull Math Biophys 12:161–169
Larson EW, Young HW, Walker JS (1976) Aerosol evaluations of the deVilbiss No. 40 and vaponefrin nebulizers. Appl Environ Microbiol 31:150–151
La Tessa A, Teng C, Katrzin H (1954) The histo-chemistry of the basement membrane of the cornea. Am J Ophthalmol 58:171
Levenson JE (1973) The effect of short term drying on the surface ultrastructure of the rabbit cornea: a scanning electron microscopic study. Ann Ophthalmol 5:865
Lindenmann J, Burke DC, Isaacs A (1957) Studies on the production, mode of action and properties of interferon. Br J Exp Path 38:551–562
Lippmann M (1970) Deposition and clearance of inhaled particles in the human nose. Ann Otol Rhinol Laryngol 79:519–529
Lucas AM, Douglas LC (1933) Direction of flow of nasal mucus. Proc Soc Exp Med Biol 31:320–321
Lucas AM, Douglas LC (1934) Principles underlying ciliary activity in the respiratory tract. II. A comparison of nasal clearance in man, monkey and other mammals. Arch Otolaryngol 20:518–541
Maurice D (1957) The structure and transparency of the cornea. J Physiol 136:263–270
McGill JI, Cantell K, Collins P, Finter NB, Laird R, Jones BR (1977) Optimal usage of exogenous human interferon for prevention or therapy of herpetic keratitis. Trans Ophthalmol Soc UK 97(2):324–326
Melville KI (1973) Antihistamine drugs. In: Schachter M (ed) Histamine and antihistamines. Pergamon, Elmsford, p 127 (International encyclopedia of pharmacology and therapeutics, vol 1)
Merigan TC, Hall TS, Reed SE, Tyrrell DAJ (1973) Inhibition of respiratory virus infection by locally applied interferon. Lancet I:563–567
Milder B (1981) The lacrimal apparatus. In: Moses RA (ed) Adler’s physiology of the eye. Mosby, St. Louis, p 16
Mishima S, Gasset A, Klyce SD Jr, Baum JL (1966) Determination of tear volume and tear flow. Invest Ophthalmol 5:265–276
Naessen R (1970) The anatomy of drainage of nasal secretions. Acta Otolaryngol 84:326–329
Negus VE (1958) The comparative anatomy and physiology of the nose and paranasal sinuses. Livingstone, Edinburgh
Neumann-Haefelin D, Sundmacher R, Skoda R, Cantell K (1977) Comparative evaluation of human leukocyte and fibroblast interferon in the prevention of herpes simplex virus keratitis in a monkey model. Infect Immunol 17(2):468–470
Pallin O, Lundmark K, Brege KG (1976) Interferon in severe herpes simplex of cornea. Lancet II:1187–1188
Parke DV (1978) Pharmacology of mucus. Br Med Bull 34:89–94
Patterson A, Fox AD, Davies G, MaGurie CH, Sellors PJ, Wright P, Rice NSC, Cobb B, Jones Br (1963) Controlled studies of IDU in the treatment of herpetic keratitis. Ophthalmol Soc UK 83:583–591
Pattle RE (1961) retention of gases and particles in the human nose. In: Davies CN (ed) Inhaled particles and vapours. Pergamon, Oxford, p 302
Potts AM (1953) The nutritional supply of corneal regions in experimental animals II. Am J Ophthalmol 36:127–133
Proctor DF, Andersen I, Lundqvist G (1973) Clearance of inhaled particles from the human nose. Arch Intern Med 131:132–139
Proctor DF, Andersen, Lundqvist G (1977) Nasal Mucociliary Function in Humans. In: Brain JD, Proctor DF, Reid LM (eds) Respiratory defense mechanisms, vol 5. Dekker, New York, p 427
Proetz AW (1953) Essays on the applied physiology of the nose. St. Louis Annals Publishing, St. Louis
Quinlan M, Salman S, Swift DL, Wagner Jr HN, Proctor DF (1969) Measurement of mucociliary function in man. Am Rev Respir Dis 99:3–23
Reznik VI, Shangina DA, Zdanovskaia NI (1978) Trial preventive use of leukocyte interferon in foci of acute respiratory diseases. Vopr Virusol 6:732–734
Romano A, Revel M, Guarari-Rotman D, Blumenthal M, Stein R (1980) Use of human fibroblast-derived (beta) interferon in the treatment of epidemic adenovirus keratoconjunctivitis. J Interferon Res 1:169–178
Rossman TG, Vilcek J (1970) Blocking of interferon action by a component of normal serum. Arch Ges Virusforsch 31:18–23
Sadunaisky JA, Spinowitz B (1976) Drugs affecting the transport and permeability of the corneal epithelium. In: Dikstein S (ed) Drugs and ocular tissues. Karger, Basel, p 57
Saketkhoo K, Yergin BM, Januszkiewicz A, Kovitz K, Sackner MA (1978) The effect of nasal decongestants on nasal mucous velocity. Am Rev Resp Dis 118:251–254
Schastny’i EI, Ritova VV, Krasnikova VA, Feklisova LV, Ulanovskaia TI (1978) Rational approach to the use of exogenous interferon for prevention of respiratory tract infections among children in medical institutions. Vopr Okhr Materin Det 23(1):87–88
Schirmer O (1903) Studien zur Physiologie und Pathologie der Tränenabsonderung und Tränenabfuhr. Albrecht Von Graefes Arch Ophthalmol 56:197–203
Schoenwald R, Ward R (1978) Relationship between steroid permeability across excised rabbit cornea and octanol-water partition coefficients. J Pharm Sci 67:786–791
Schultz EW (1960) Repair of the olfactory mucosa. Am J Pathol 37:1–19
Schuster JJ, Kaufman HE, Nesburn AB (1981) Statistical analysis of recurrence of herpes virus ocular epithelial disease. Am J Ophthalmol 91:328–329
Scientific Committee on Interferon (1962) Effect of interferon on vaccination in volunteers. Lancet I:873–875
Scientific Committee on Interferon (1965) Experiments with interferon in man. Lancet I:505–506
Scott GM, Csonka GW (1979) Effect of injections of small doses of human fibroblast interferon into genital warts. A pilot study. Br J Vener Dis 55(6):442–445
Scott GM, Cartwright T, LeDu G, Dicker D (1978) Effect of human fibroblast interferon on vaccination in volunteers. J Biol Stand 6:73–76
Scott GM, Reed S, Cartwright T, Tyrrell D (1980) Failure of human fibroblast interferon to protect against rhino virus infection. Arch Virol 65(2): 135–139
Solov’ev VD (1967) Some results and prospects in the study of endogenous and exogenous interferon. In: G Rita (ed) The interferons. Academic, New York, p 233
Solov’ev VD (1969) The results of controlled observations on the prophylaxis of influenza with interferon. Bull WHO 41:683–688
Soos E, Ikic D, Jusic D, Smerdel S, Petricevic I, Kunsten D, Soldo I (1972) Treatment of local complications provoked by vaccinia virus with leukocytic interferon. Proc symp on combined vaccines, Yugoslavia Academy Sciences and Arts, Zagreb, pp 179–182
Stocksted P (1952) The physiologic cycle of the nose under normal and pathologic conditions. Acta Otolaryngol (Stockh) 42:175–181
Sugar J, Kaufman HE, Varnell ED (1973) Effect of exogenous interferon on herpetic keratitis in rabbits and monkeys. Invest Ophthalmol 12:378–379
Sundmacher R, Neumann-Haefelin D, Manthey KF, Muller O (1976a) Interferon in treatment of dendritic keratitis in humans: a preliminary report. J Infect Dis 133:160–164
Sundmacher R, Neumann-Haeflin D, Cantell K (1976b) Successful treatment of dendritic keratitis with human leukocyte interferon. Albrecht Von Graefes Arch Klin Exp Ophthalmol 201:39–45
Sundmacher R, Neumann-Haefelin D, Manthey KF (1977) Human-interferon therapy in dendritic keratitis. Ber Zusammenkunft Dtsch Ophthalmol Ges 74:615–618
Sundmacher R, Cantell K, Haug P, Neumann-Haefelin D (1978a) Role of debridement and interferon in the treatment of dendritic keratitis. Albrecht Von Graefes Arch Klin Exp Ophthalmol 207:77–82
Sundmacher R, Cantell K, Skoda R, Hallermann C, Neumann-Haefelin D (1978b) Human leukocyte and fibroblast interferon in a combination therapy of dendritic keratitis. Albrecht Von Graefes Arch Klin Exp Ophthalmol 208:229–233
Sundmacher R, Cantell K, Haug P, Neumann-Haefelin D (1978c) Interferon prophylaxis of dendritic keratitis recurrence during local steroid therapy. Ber Zusammenkunft Dtsch Ophthalmol Ges 75:344–346
Sundmacher R, Cantell K, Neumann-Haefelin D (1981) Evaluation of interferon in ocular viral diseases. In: Schellekens H, Maeyer E de, Galasso G (eds) The biology of the interferon system. Interferon meeting, 21–24 April 1981. Elsevier/North Holland, Amsterdam
Swan K, White N (1942) Corneal permeability: factors affecting penetration of drugs into the cornea. Am J Ophthalmol 25:1043
Taylor M (1974) The origin and functions of nasal mucus. Laryngoscope 84:612–621
Tommila V (1963) Treatment of dendritic keratitis with interferon. Acta Ophthalmol 41:478–482
Tyrrell DAJ, Reed SE (1973) Some possible practical implications of interferon and interference. In: Brown W, Unger J (eds) Non-specific factors influencing host resistance. Karger, Basel, p 438
Waltman SR (1981) The cornea. In: Moses RA (ed) Adler’s physiology of the eye. Mosby, St. Louis, p 38
Wanner A (1977) Clinical aspects of mucociliary transport. Am Rev Resp Dis 116:73–125
Widdicombe JG (1978) Control of secretion of tracheobronchial mucus. Br Med Bul 34:57–61
Yunde H, Guoliang M, Shuhua W, Yuying L, Hantang L (1981) Effect of radix astragali seu hedysari on the interferon system. Chinese Med J 94:35–40
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1984 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Greenberg, S.B., Harmon, M.W. (1984). Clinical Use of Interferons: Localized Application in Viral Diseases. In: Came, P.E., Carter, W.A. (eds) Interferons and Their Applications. Handbook of Experimental Pharmacology, vol 71. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-69178-2_21
Download citation
DOI: https://doi.org/10.1007/978-3-642-69178-2_21
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-69180-5
Online ISBN: 978-3-642-69178-2
eBook Packages: Springer Book Archive